Kovitz Investment Group Partners, LLC - SPDR SER TR ownership

SPDR SER TR's ticker is XBI and the CUSIP is 78464A870. A total of 685 filers reported holding SPDR SER TR in Q3 2023. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
Kovitz Investment Group Partners, LLC ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$5,038,891
-4.1%
69,007
+9.3%
0.09%
+18.2%
Q2 2023$5,254,163
+102061.4%
63,151
-6.4%
0.08%
-13.5%
Q1 2023$5,143
-20.8%
67,486
-13.8%
0.09%
-30.5%
Q4 2022$6,496
-99.9%
78,261
+22.1%
0.13%
+8.5%
Q3 2022$5,083,000
+12.8%
64,082
+5.6%
0.12%
+18.0%
Q2 2022$4,507,000
-15.4%
60,683
+2.3%
0.10%
-2.0%
Q1 2022$5,329,000
+21.7%
59,295
+90.7%
0.10%
-1.0%
Q4 2021$4,378,000
+21.6%
31,100
+8.6%
0.10%
+43.1%
Q3 2021$3,601,000
-13.3%
28,646
-6.6%
0.07%
-12.2%
Q2 2021$4,154,000
+10.9%
30,676
+11.1%
0.08%
-5.7%
Q1 2021$3,745,000
-14.3%
27,610
-11.1%
0.09%
-17.9%
Q4 2020$4,371,000
+18.0%
31,045
-6.6%
0.11%
+1.9%
Q3 2020$3,704,000
-6.2%
33,240
-5.7%
0.10%
-14.8%
Q2 2020$3,947,000
+14.8%
35,260
-20.6%
0.12%
-1.6%
Q1 2020$3,438,000
-10.8%
44,395
+9.5%
0.12%
+10.7%
Q4 2019$3,856,000
+24.7%
40,540
-0.0%
0.11%
+14.3%
Q3 2019$3,093,000
-12.9%
40,560
+0.2%
0.10%
-12.5%
Q2 2019$3,550,000
-4.0%
40,475
-0.9%
0.11%
-4.3%
Q1 2019$3,699,000
+1322.7%
40,860
+1262.0%
0.12%
+800.0%
Q3 2017$260,000
-9.1%
3,000
-18.9%
0.01%
-13.3%
Q2 2017$286,000
-41.9%
3,700
-47.9%
0.02%
-44.4%
Q1 2017$492,0007,1000.03%
Other shareholders
SPDR SER TR shareholders Q3 2023
NameSharesValueWeighting ↓
TradeLink Capital LLC 56,250$4,462,00083.28%
Artal Group S.A. 5,000,000$396,600,00016.93%
Aquilo Capital Management, LLC 500,000$39,660,00014.30%
DAFNA Capital Management LLC 566,000$44,895,00012.08%
AMS Capital Ltda 232,905$19,080,00012.07%
Parkwood LLC 950,000$75,354,00011.42%
Ghost Tree Capital, LLC 500,000$39,660,00011.13%
Q Global Advisors, LLC 191,472$15,729,00010.82%
Main Management Fund Advisors LLC 159,400$12,644,0009.08%
Investure, LLC 561,600$44,546,1128.75%
View complete list of SPDR SER TR shareholders